The authors of this study emphasize the effectiveness of collectively funded public insurances as opposed to genetic information regulation within the private insurance sector. Genetics has provided tools to determine individuals’ risk of future disease, which is of key interest for insurance companies in determining insurance premiums; but persons with high enough risk may remain uninsured. For this reason, genetic information has been regulated. But, regulation may not be the solution, according to the authors, and they call for the resumption of social insurance, a key element of the welfare state.
![[PDF] Genes and Insurance: Ethical, Legal and Economic Issues Keith Syrett](https://digzon.com/wp-content/uploads/2024/04/6417644d8635baaf7ae291dd6a24f6a2-d.jpg)
![[PDF] Parkinson's Disease: Methods & Protocols (Methods in Molecular Medicine) Maral Mouradian](https://digzon.com/wp-content/uploads/2024/04/17da01ab3d3e6f6f879bc58a177c06d6-d.jpg)
![[PDF] On-Site Drug Testing (Forensic Science and Medicine) Amanda J. Jenkins, Bruce A. Goldberger](https://digzon.com/wp-content/uploads/2024/04/17117f2af39627000729368cee78eec3-d.jpg)
![[PDF] Innovations in Medicine and Health: Diffusion and Resistance in the Twentieth Century (Routledge Studies in the Social History of Medicine) J. Stanton](https://digzon.com/wp-content/uploads/2024/04/1359b922f6aa2f4dd18023d6cf4ad4a1-d.jpg)
![[PDF] Optimization in Medicine Ryan Acosta, Matthias Ehrgott, Allen Holder, Daniel Nevin (auth.), Carlos J. S. Alves, Panos M. Pardalos, Luis Nunes Vicente (eds.)](https://digzon.com/wp-content/uploads/2024/04/15914d2c39dc92f4d7309e8e1b2dc97f-d.jpg)
Reviews
There are no reviews yet.